What would we do without you here!

Do you know of any trials out there where they were successful for a 5 point MACE but not a 3 point MACE.

The phase 2 trials for apabetalone were all for 5 point and they got good RRR,... and I think the company said reduce it by 10% and you should get the 3 point RRR,... is that possible to say,... especially knowing the company has acces to all the blinded data,..?

I love the MOA of our drug and it goes a long way to having confidence that the top line data will be positive (above 25% RRR).

Thanks!